Division of Trauma, Critical Care and Acute Care Surgery, Department of Surgery, School of Medicine, Oregon Health and Science University, Portland, Oregon 97239-3098, USA.
J Trauma Acute Care Surg. 2013 Jul;75(1 Suppl 1):S9-15. doi: 10.1097/TA.0b013e318290cd52.
Delivery of intravenous crystalloid fluids (IVF) remains a tradition-based priority during prehospital resuscitation of trauma patients. Hypotensive and targeted resuscitation algorithms have been shown to improve patient outcomes. We hypothesized that receiving any prehospital IVF is associated with increased survival in trauma patients compared with receiving no prehospital IVF.
Prospective data from 10 Level 1 trauma centers were collected. Patient demographics, prehospital IVF volume, prehospital and emergency department vital signs, lifesaving interventions, laboratory values, outcomes, and complications were collected and analyzed. Patients who did or did not receive prehospital IVF were compared. Tests for nonparametric data were used to assess significant differences between groups (p ≤ 0.05). Cox regression analyses were performed to determine the independent influence of IVF on outcome and complications.
The study population consisted of 1,245 trauma patients; 45 were excluded owing to incomplete data; 84% (n = 1,009) received prehospital IVF, and 16% (n = 191) did not. There was no difference between the groups with respect to sex, age, and Injury Severity Score (ISS). The on-scene systolic blood pressure was lower in the IVF group (110 mm Hg vs. 100 mm Hg, p < 0.04) and did not change significantly after IVF, measured at emergency department admission (110 mm Hg vs. 105 mm Hg, p = 0.05). Hematocrit/hemoglobin, fibrinogen, and platelets were lower (p < 0.05), and prothrombin time/international normalized ratio and partial thromboplastin time were higher (p < 0.001) in the IVF group. The IVF group received a median fluid volume of 700 mL (interquartile range, 300-1,300). The Cox regression revealed that prehospital fluid administration was associated with increased survival (hazard ratio, 0.84; 95% confidence interval, 0.72-0.98; p = 0.03). Site differences in ISS and fluid volumes were demonstrated (p < 0.001).
Prehospital IVF volumes commonly used by PRospective Observational Multicenter Massive Transfusion Study (PROMMTT) investigators do not result in increased systolic blood pressure but are associated with decreased in-hospital mortality in trauma patients compared with patients who did not receive prehospital IVF.
在创伤患者的院前复苏中,静脉输注晶体液(IVF)仍然是基于传统的优先事项。低血压和目标复苏算法已被证明可改善患者的预后。我们假设与未接受院前 IVF 相比,接受任何院前 IVF 与创伤患者的生存率提高有关。
前瞻性收集 10 个 1 级创伤中心的数据。收集患者的人口统计学数据、院前 IVF 量、院前和急诊科生命体征、救生干预措施、实验室值、结局和并发症,并进行分析。比较接受或未接受院前 IVF 的患者。使用非参数数据检验评估组间的显著差异(p≤0.05)。进行 Cox 回归分析以确定 IVF 对结局和并发症的独立影响。
研究人群包括 1245 例创伤患者;由于数据不完整,有 45 例被排除在外;84%(n=1009)接受了院前 IVF,16%(n=191)未接受。两组在性别、年龄和损伤严重程度评分(ISS)方面无差异。IVF 组的现场收缩压较低(110mmHg 比 100mmHg,p<0.04),在急诊科入院时测量的 IVF 后收缩压无明显变化(110mmHg 比 105mmHg,p=0.05)。IVF 组的血细胞比容/血红蛋白、纤维蛋白原和血小板较低(p<0.05),凝血酶原时间/国际标准化比值和部分凝血活酶时间较高(p<0.001)。IVF 组中位数的液体量为 700mL(四分位距 300-1300)。Cox 回归显示,院前液体给药与生存率增加相关(危险比 0.84;95%置信区间 0.72-0.98;p=0.03)。ISS 和液体量的部位差异显著(p<0.001)。
PROMMTT 研究人员常用的院前 IVF 量不会导致收缩压升高,但与未接受院前 IVF 的患者相比,创伤患者的院内死亡率降低。